A Pilot Study to Evaluate the Therapeutic Effect of Dihydroartemisinin on Acne Vulgaris
Status: Recruiting
Location: See location...
Intervention Type: Drug
Study Type: Interventional
Study Phase: Early Phase 1
SUMMARY
The goal of this clinical trial is to learn if dihydroartemisinin (DHA) works to treat Acne Vulgaris in adults. The main question it aims to answer is: • Does DHA improve the acne severity by at least one grade after treatment. Researchers will treat patients who are clinically diagnosed as Acne Vulgaris to see if DHA works to alleviate the symptoms of Acne Vulgaris. Participants will: * Take DHA every day for 3 months * Visit the clinic once every month for checkups and tests
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 40
Healthy Volunteers: f
View:
• Clinically diagnosed with acne vulgaris;
• For female patients, no pregnancy plans within the next 6 months.
Locations
Other Locations
China
Zhongshan Hospital Fudan University
RECRUITING
Shanghai
Contact Information
Primary
Lujuan GAO, MD, PhD
gao.lujuan@zs-hospital.sh.cn
86-021-64041990
Time Frame
Start Date: 2025-06
Estimated Completion Date: 2026-12
Participants
Target number of participants: 60
Treatments
Experimental: DHA (dihydroartemisinin) Arm
Related Therapeutic Areas
Sponsors
Leads: Shanghai Zhongshan Hospital